mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.001 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |